Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series Pharmaceutical Investing
Alder BioPharmaceuticals Presents New 12-Month Data of Eptinezumab in PROMISE 1 Phase 3 Trial Showing Long-Term Reduction in Episodic Migraine Biotech Investing
Precision Therapeutics Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares Pharmaceutical Investing
Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA Pharmaceutical Investing
Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin Pharmaceutical Investing
AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II Biotech Investing
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease Pharmaceutical Investing
Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas Pharmaceutical Investing
Xanthic Biopharma Inc. Announces LOI with Licensed Producer, Green Mile Solutions LLC, for Production and Sale of Xanthic-Infused Products in Oregon, Nevada and Ohio Cannabis Investing News
